This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Anaplamsa Antigen
Product Overview
BioVenic's Recombinant Anaplamsa Antigen is a recombinant antigen produced by E.coli. This antigen has undergone a rigorous purification process. It can be used for ELISA plate coating or for the preparation of enzyme conjugates.
Specifications
Target Information
Anaplasma is a genus of obligate intracellular, Gram-negative bacteria transmitted by ixodid ticks, primarily causing anaplasmosis in ruminants, canines, and humans. These pathogens selectively infect mature erythrocytes or granulocytes, replicating within membrane-bound vacuoles. Key diagnostic and therapeutic targets include major surface proteins such as MSP1a, MSP2, and MSP4, which are critical for host cell adhesion, infection, and tick vector colonization, as well as tools for antigenic variation used to evade host immune responses.
Shipping and Storage
This product is shipped with gel ice bags. Store at 0-4°C for no more than 2 weeks, or -20°C or below for long-term storage.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.